Midatech Pharma plc
Midatech Pharma plc (MTP) Revenue
Annual & quarterly revenue history · segment & region breakdown
MTP · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsMidatech Pharma plc trailing twelve-month (TTM) revenue is $0.00B, a decrease of 100.00% year-over-year from $0.00B in FY2024.
Revenue trend
2024 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2024-12-31 | $0.00B | -$0.00B | -100.00% |
| 2023-12-31 | $0.00B | -$0.00B | -45.49% |
| 2022-12-31 | $0.00B | +$0.00B | +20.93% |
| 2021-12-31 | $0.00B | +$0.00B | +68.51% |
| 2020-12-31 | $0.00B | -$0.00B | -49.11% |
| 2019-12-31 | $0.00B | -$0.00B | -65.22% |
| 2018-12-31 | $0.00B | +$0.00B | +95.96% |
| 2017-12-31 | $0.00B | -$0.00B | -25.25% |
| 2016-12-31 | $0.00B | -$0.00B | -3.78% |
| 2015-12-31 | $0.00B | +$0.00B | +775.80% |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Midatech Pharma plc receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Midatech Pharma plc reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in GBP.
Data sourced from Midatech Pharma plc's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MTP revenue · 4 questionsMTP's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 100.00% year-over-year from $0.00B in FY2024.
▸ Source: FMP · Midatech Pharma plc SEC filings · GAAP · Midatech Pharma plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026